← Other lipid agents × cardiovascular events

SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2023

Bempedoic Acid can Reduce Cardiovascular Events in Combination with Statins or As Monotherapy: A Systematic Review and Meta-analysis.

Ju Zhang et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 17,323 people · 2023

Randomised comparison

Reduced cardiovascular events

−24%−34% to −11%

Bigger than 6 in 10 for cardiovascular events

As reported

RR 0.76, 95% CI 0.66–0.89

Randomised comparison

Reduced cardiovascular events

−30%−45% to −11%

Bigger than 7 in 10 for cardiovascular events

As reported

RR 0.70, 95% CI 0.55–0.89

Randomised comparison

Reduced cardiovascular events

−18%−27% to −8%

Bigger than 4 in 10 for cardiovascular events

As reported

RR 0.82, 95% CI 0.73–0.92

Three numbers in the abstract

the abstract, start to end

… or nonfatal myocardial infarction (RR 0.76, 95% CI 0.66-0.89), hospitalization for unstable angina (RR 0.70, 95% CI 0.55-0.89), and coronary revascularization (RR 0.82, 95% CI 0.73-0.92).

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
RR 0.760.66–0.89
Cardiovascular events
RR 0.700.55–0.89
Cardiovascular events
RR 0.820.73–0.92
Other lipid agentsCardiovascular events
1 / 3

3 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37672202